Brighter recruits expert to support the development and launch of Actiste.

In connection to the upcoming launch of Actiste®, Brighter’s new advisor Jorge C. Otero is an important link to the global pharmaceutical industry. Together with the company's management Jorge C. Otero will develop the go to market strategies for Actiste and evaluate additional business areas in which the product can be applied, in addition to diabetes. Jorge C. Otero, MD, has an extensive and documented background in the pharmaceutical industry and has been a senior executive for clinical development and medical affairs at large pharmaceutical companies such as Eli Lilly,